SOD1 and prostate carcinoma: Numerous studies have demonstrated an imbalance in oxidative stress/redox status and a compromised GPX/Thiol antioxidant system in prostate cancer patients, accompanied by reduced activities of superoxide dismutase (SOD), GPX, GSH, and catalase (CAT) compared to controls.